









Markets
/
Stocks
/
nasdaq-mass
/

908 Devices Inc.

MASS

6.550USD

+0.350+5.65%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

236.58MMarket Cap

LossP/E TTM



908 Devices Inc.

6.550

+0.350+5.65%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of 908 Devices Inc.

Currency: USD Updated: 2026-02-06

Key Insights

908 Devices Inc.'s fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 38 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 10.00.In the medium term, the stock price is expected to remain stable.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

908 Devices Inc.'s Score

Industry at a Glance

Industry Ranking

38 / 205

Overall Ranking

126 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

908 Devices Inc. Highlights

StrengthsRisks

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 27.28% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 59.63M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 59.63M.

Undervalued

The company’s latest PE is -50.03, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 32.89M shares, decreasing 13.82% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 2.69K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.58.

Analyst Rating

Based on 4 analysts

Strong Buy

Current Rating

10.000

Target Price

+57.98%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of 908 Devices Inc. is 6.97, ranking 115 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 14.01M, representing a year-over-year decrease of 16.50%, while its net profit experienced a year-over-year decrease of 48.86%.

Score

Industry at a Glance

Previous score

6.97

Change



Financials

8.94

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.71

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.28

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.87

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.07

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

908 Devices Inc.'s Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of 908 Devices Inc. is 8.19, ranking 41 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -50.03, which is -98.13% below the recent high of -0.93 and -6.87% above the recent low of -53.47.

Score

Industry at a Glance

Previous score

8.19

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 38/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of 908 Devices Inc. is 9.50, ranking 2 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 10.00, with a high of 12.00 and a low of 8.00.

Score

Industry at a Glance

Previous score

9.50

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 4 analysts

Strong Buy

Current Rating

10.000

Target Price

+57.98%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

908 Devices Inc.

MASS

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of 908 Devices Inc. is 7.14, ranking 50 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 7.56 and the support level at 5.44, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.93

Change

0.21

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.001

Neutral

RSI(14)

57.202

Neutral

STOCH(KDJ)(9,3,3)

38.883

Buy

ATR(14)

0.479

Low Volatility

CCI(14)

-17.796

Neutral

Williams %R

65.246

Sell

TRIX(12,20)

0.586

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

6.342

Buy

MA10

6.440

Buy

MA20

6.208

Buy

MA50

6.014

Buy

MA100

6.808

Sell

MA200

6.522

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of 908 Devices Inc. is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 90.87%, representing a quarter-over-quarter increase of 11.98%. The largest institutional shareholder is Catherine Wood, holding a total of 1.95M shares, representing 5.40% of shares outstanding, with 33.23% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

ARCH Venture Partners

5.73M

AWM Investment Company, Inc.

5.20M

First Light Asset Management, LLC

4.68M

+86.45%

State Street Investment Management (US)

2.30M

+0.50%

ARK Investment Management LLC

Star Investors

1.95M

-26.22%

BlackRock Institutional Trust Company, N.A.

1.60M

-1.27%

The Vanguard Group, Inc.

Star Investors

1.42M

-0.66%

Knopp (Kevin J)

1.26M

+2.43%

Brown (Christopher D)

962.12K

GM Advisory Group, LLC

678.09K

-41.81%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of 908 Devices Inc. is 3.56, ranking 122 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.49. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.